Investor relations
Investor resources
Upcoming earnings dates
Q1 2025: May 1
Contact Investor Relations
Investor Relations
One IDEXX Drive
Westbrook, Maine 04092
1-207-556-8155
or 1-800-548-6733
Fax: 1-207-556-4427
Email
Transfer agent
EQ
General communications for shareholders
PO Box 500
Newark, NJ 07101
Attn: Shareowner Services
Inquiries may also be sent to helpAST@equiniti.com
EQ online portal https://equiniti.com/us/ast-access/individuals/
Telephone: 1-800-937-5449 (toll free).
Shareholders outside of the U.S. and Canada can call 1-718-921-8124.
Overnight Address
The address for items such as certificates, stock powers, legal paperwork, checks, loss affidavits that require ‘wet’ signatures, etc.
EQ
55 Challenger Road, Floor 2
Ridgefield Park, NJ 07660
Attn: Shareowner Services
Analyst coverage*
| Investor firm | Analyst |
| Bank of America | Michael Ryskin |
| BNP Paribus Exane | Navann Ty Dietschi |
| Cleveland Research | Andrew Dusing |
| J.P. Morgan | Chris Schott |
| Leerink Partners | Daniel Clark |
| Morgan Stanley | Erin Wright |
| Morningstar | Debbie Wang |
| Nephron Research | Tom DeBourcy |
| Piper Sandler | David Westenberg |
| Redburn Atlantic | Steve Chesney |
| Stifel Nicolaus | Jonathan Block |
| William Blair | Ryan Daniels |
*IDEXX Laboratories is currently followed by the analysts listed above; this list may not be complete and is subject to change. Please note that any opinions, estimates, or forecasts regarding IDEXX Laboratories' historical or predicted performance made by analysts at these firms are theirs alone and do not represent opinions, forecasts, or predictions of IDEXX Laboratories or its management. IDEXX Laboratories is providing this listing as a service to investors and stockholders and does not by listing these firms imply its endorsement of or concurrence with any information, conclusions, or recommendations expressed by such analysts. Interested persons must obtain copies of analyst reports on their own; IDEXX Laboratories does not distribute these reports..